Insmed (INSM) News Today $74.54 +0.04 (+0.05%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 10:07 AM | msn.comThese Signs Show Which Stocks Are Having A Hidden Rally, Says Mark MinerviniJuly 26 at 4:39 AM | marketbeat.comSei Investments Co. Lowers Holdings in Insmed Incorporated (NASDAQ:INSM)Sei Investments Co. trimmed its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 17.5% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 81,073 shares of the biopharmaceutical company's stJuly 24 at 6:14 PM | marketbeat.comClearbridge Investments LLC Makes New Investment in Insmed Incorporated (NASDAQ:INSM)Clearbridge Investments LLC purchased a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 930,409 shares of the biopharmaceuticJuly 22, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Sold by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC trimmed its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 62.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,301 shares of the biopharmaceutical company's stockJuly 21, 2024 | markets.businessinsider.comExploring Insmed's Key Growth Drivers...July 19, 2024 | finance.yahoo.comInsmed Incorporated (INSM)July 19, 2024 | benzinga.comHere's How Much $100 Invested In Insmed 10 Years Ago Would Be Worth TodayJuly 19, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Sold by Scout Investments Inc.Scout Investments Inc. lessened its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 6.0% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 275,670 shares of the biopharmaceutical company's stock after selling 17,527 shares during the period. Scout IJuly 19, 2024 | americanbankingnews.comBrokerages Set Insmed Incorporated (NASDAQ:INSM) Price Target at $74.50July 18, 2024 | marketbeat.comStock Rotation is Underway: Here are the Winners Moving Forward (INSM)The CPI report sparked a massive sector rotation; investors are shedding overbought big tech names like Microsoft and NVIDIA in favor of risk-on assets.July 17, 2024 | americanbankingnews.comInsmed (NASDAQ:INSM) Reaches New 1-Year High on Analyst UpgradeJuly 16, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Short Interest Up 10.9% in JuneInsmed Incorporated (NASDAQ:INSM - Get Free Report) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totalling 12,830,000 shares, a growth of 10.9% from the June 15th total of 11,570,000 shares. Based on an average daily trading volume, of 3,470,000 shares, the days-to-cover ratio is currently 3.7 days.July 16, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Given Average Rating of "Buy" by BrokeragesInsmed Incorporated (NASDAQ:INSM - Get Free Report) has been given an average recommendation of "Buy" by the sixteen brokerages that are covering the company, Marketbeat.com reports. Sixteen investment analysts have rated the stock with a buy rating. The average 12-month price objective among brokJuly 15, 2024 | marketbeat.comInsmed (NASDAQ:INSM) Sets New 1-Year High Following Analyst UpgradeInsmed (NASDAQ:INSM) Reaches New 52-Week High on Analyst UpgradeJuly 15, 2024 | marketbeat.comSusquehanna Fundamental Investments LLC Buys New Shares in Insmed Incorporated (NASDAQ:INSM)Susquehanna Fundamental Investments LLC bought a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The firm bought 166,409 shares of the biopharmaceutical company's stock, valued at approximatelJuly 14, 2024 | marketbeat.comSusquehanna Portfolio Strategies LLC Reduces Position in Insmed Incorporated (NASDAQ:INSM)Susquehanna Portfolio Strategies LLC decreased its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 87.0% in the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 21,419 shares of the biopharmaceutical company's stock after selling 143,077 sharesJuly 12, 2024 | marketbeat.comInsmed (NASDAQ:INSM) Sees Large Volume Increase After Analyst UpgradeInsmed (NASDAQ:INSM) Sees Strong Trading Volume After Analyst UpgradeJuly 12, 2024 | marketbeat.comInsmed (NASDAQ:INSM) Price Target Raised to $85.00 at Morgan StanleyMorgan Stanley lifted their target price on Insmed from $60.00 to $85.00 and gave the stock an "overweight" rating in a report on Friday.July 10, 2024 | marketbeat.comHC Wainwright Analysts Raise Earnings Estimates for Insmed Incorporated (NASDAQ:INSM)Insmed Incorporated (NASDAQ:INSM - Free Report) - Equities research analysts at HC Wainwright lifted their FY2025 earnings per share estimates for shares of Insmed in a report issued on Monday, July 8th. HC Wainwright analyst A. Fein now forecasts that the biopharmaceutical company will post earnJuly 9, 2024 | marketbeat.comInsmed (NASDAQ:INSM) PT Raised to $95.00 at GuggenheimGuggenheim raised their price target on Insmed from $70.00 to $95.00 and gave the stock a "buy" rating in a research note on Tuesday.July 8, 2024 | marketbeat.comInsmed (NASDAQ:INSM) Reaches New 52-Week High Following Analyst UpgradeInsmed (NASDAQ:INSM) Sets New 1-Year High Following Analyst UpgradeJuly 8, 2024 | marketbeat.comHC Wainwright Increases Insmed (NASDAQ:INSM) Price Target to $90.00HC Wainwright boosted their target price on Insmed from $70.00 to $90.00 and gave the company a "buy" rating in a research note on Monday.July 5, 2024 | marketbeat.comInsmed (NASDAQ:INSM) Stock Price Up 7.5%Insmed (NASDAQ:INSM) Trading Up 7.5%July 5, 2024 | marketbeat.comInsmed's (INSM) Buy Rating Reaffirmed at Bank of AmericaBank of America restated a "buy" rating and issued a $83.00 target price on shares of Insmed in a research note on Friday.July 5, 2024 | prnewswire.comInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)July 3, 2024 | marketbeat.comInsmed (NASDAQ:INSM) Shares Down 3.7% Insmed (NASDAQ:INSM) Trading Down 3.7%July 3, 2024 | prnewswire.comAdditional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis ConferenceJuly 3, 2024 | marketbeat.comShort Interest in Insmed Incorporated (NASDAQ:INSM) Grows By 6.5%Insmed Incorporated (NASDAQ:INSM - Get Free Report) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totalling 11,570,000 shares, a growth of 6.5% from the May 31st total of 10,860,000 shares. Based on an average daily volume of 3,270,000 shares, the short-interest ratio is currently 3.5 days.July 3, 2024 | marketbeat.com25,000 Shares in Insmed Incorporated (NASDAQ:INSM) Purchased by Requisite Capital Management LLCRequisite Capital Management LLC acquired a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 25,000 shares of the biopharmaceuticalJuly 2, 2024 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Insmed (NASDAQ:INSM)HC Wainwright restated a "buy" rating and issued a $70.00 price target on shares of Insmed in a research note on Tuesday.June 27, 2024 | prnewswire.comInsmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025June 27, 2024 | marketbeat.comVanguard Group Inc. Cuts Position in Insmed Incorporated (NASDAQ:INSM)Vanguard Group Inc. lowered its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 1.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,125,521 shares of the biopharmaceutical company's stock after sellJune 25, 2024 | marketbeat.comGoldman Sachs Group Inc. Lowers Position in Insmed Incorporated (NASDAQ:INSM)Goldman Sachs Group Inc. reduced its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 11.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 761,772 shares of the biopharmaceutical coJune 21, 2024 | marketbeat.comEvercore ISI Boosts Insmed (NASDAQ:INSM) Price Target to $75.00Evercore ISI increased their price target on Insmed from $42.00 to $75.00 and gave the stock an "outperform" rating in a report on Friday.June 21, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Given Consensus Rating of "Buy" by BrokeragesInsmed Incorporated (NASDAQ:INSM - Get Free Report) has been given an average recommendation of "Buy" by the sixteen brokerages that are covering the stock, Marketbeat reports. Sixteen equities research analysts have rated the stock with a buy recommendation. The average 1 year price target amongJune 20, 2024 | marketbeat.comCantor Fitzgerald Reaffirms Overweight Rating for Insmed (NASDAQ:INSM)Cantor Fitzgerald restated an "overweight" rating on shares of Insmed in a research note on Thursday.June 20, 2024 | marketbeat.comInsmed (NASDAQ:INSM) PT Raised to $72.00JPMorgan Chase & Co. raised their price target on shares of Insmed from $55.00 to $72.00 and gave the company an "overweight" rating in a report on Thursday.June 18, 2024 | marketbeat.comInsmed (NASDAQ:INSM) Reaches New 52-Week High at $65.41Insmed (NASDAQ:INSM) Hits New 12-Month High at $65.41June 17, 2024 | marketbeat.comKingdon Capital Management L.L.C. Buys Shares of 405,000 Insmed Incorporated (NASDAQ:INSM)Kingdon Capital Management L.L.C. bought a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 405,000 shares of the biopharmaceutical company's stock, valued at apJune 14, 2024 | marketbeat.comInsmed (NASDAQ:INSM) Trading Up 3.6%Insmed (NASDAQ:INSM) Shares Up 3.6%June 13, 2024 | marketbeat.comParkman Healthcare Partners LLC Boosts Stake in Insmed Incorporated (NASDAQ:INSM)Parkman Healthcare Partners LLC increased its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 20.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 150,816 shares of the biopharmaceutical company's stock after buyJune 13, 2024 | marketbeat.comStock Traders Purchase Large Volume of Insmed Call Options (NASDAQ:INSM)Insmed Incorporated (NASDAQ:INSM - Get Free Report) was the target of unusually large options trading on Thursday. Stock traders purchased 10,561 call options on the stock. This represents an increase of approximately 215% compared to the typical daily volume of 3,356 call options.June 12, 2024 | marketbeat.comInsmed (NASDAQ:INSM) Hits New 1-Year High at $63.23Insmed (NASDAQ:INSM) Sets New 1-Year High at $63.23June 12, 2024 | marketbeat.comEquities Analysts Set Expectations for Insmed Incorporated's Q2 2024 Earnings (NASDAQ:INSM)Insmed Incorporated (NASDAQ:INSM - Free Report) - Investment analysts at Leerink Partnrs boosted their Q2 2024 earnings per share (EPS) estimates for Insmed in a research report issued to clients and investors on Monday, June 10th. Leerink Partnrs analyst J. Schwartz now anticipates that the biopJune 10, 2024 | marketbeat.comArtia Global Partners LP Purchases Shares of 74,936 Insmed Incorporated (NASDAQ:INSM)Artia Global Partners LP purchased a new stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 74,936 shares of the biopharmaceutical company's stock, vJune 9, 2024 | marketbeat.comSeven Eight Capital LP Raises Position in Insmed Incorporated (NASDAQ:INSM)Seven Eight Capital LP grew its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 85.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 96,777 shares of the biopharmaceutical compaJune 8, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Position Reduced by Sectoral Asset Management Inc.Sectoral Asset Management Inc. cut its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 96.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,811 shares of the biopharmaceuticalJune 7, 2024 | prnewswire.comInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)June 7, 2024 | marketbeat.comFY2024 EPS Estimates for Insmed Incorporated (NASDAQ:INSM) Decreased by AnalystInsmed Incorporated (NASDAQ:INSM - Free Report) - Analysts at Cantor Fitzgerald cut their FY2024 earnings estimates for shares of Insmed in a research report issued on Tuesday, June 4th. Cantor Fitzgerald analyst J. Kim now expects that the biopharmaceutical company will earn ($4.59) per share foJune 6, 2024 | marketbeat.comInsmed (NASDAQ:INSM) Reaches New 1-Year High at $58.99Insmed (NASDAQ:INSM) Reaches New 12-Month High at $58.99 Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Nvidia insiders dumping shares (Ad)All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can. To see Porter Stansberry's new AI prediction go here now. INSM Media Mentions By Week INSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INSM News Sentiment▼0.800.61▲Average Medical News Sentiment INSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INSM Articles This Week▼75▲INSM Articles Average Week Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TG Therapeutics News Today PTC Therapeutics News Today Schrödinger News Today Emergent BioSolutions News Today Sage Therapeutics News Today FibroGen News Today Takeda Pharmaceutical News Today Alnylam Pharmaceuticals News Today Teva Pharmaceutical Industries News Today Genmab A/S News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INSM) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insmed Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Insmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
